MCLA-158 + Pembrolizumab clinical trials

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

This study is looking at a new drug called MCLA-158 for advanced cancers like bowel and head and neck cancer. It aims to find the safest dose and see how well it works alone or with other treatments. It's for patients whose cancer has spread or come back.